de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Paper

Towards Multiple Kernel Principal Component Analysis for Integrative Analysis of Tumor Samples

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons45530

Speicher,  Nora K.
Computational Biology and Applied Algorithmics, MPI for Informatics, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons98170

Pfeifer,  Nico
Computational Biology and Applied Algorithmics, MPI for Informatics, Max Planck Society;

Locator
There are no locators available
Fulltext (public)

arXiv:1701.00422.pdf
(Preprint), 62KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Speicher, N. K., & Pfeifer, N. (2017). Towards Multiple Kernel Principal Component Analysis for Integrative Analysis of Tumor Samples. Retrieved from http://arxiv.org/abs/1701.00422.


Cite as: http://hdl.handle.net/11858/00-001M-0000-002C-4D68-3
Abstract
Personalized treatment of patients based on tissue-specific cancer subtypes has strongly increased the efficacy of the chosen therapies. Even though the amount of data measured for cancer patients has increased over the last years, most cancer subtypes are still diagnosed based on individual data sources (e.g. gene expression data). We propose an unsupervised data integration method based on kernel principal component analysis. Principal component analysis is one of the most widely used techniques in data analysis. Unfortunately, the straight-forward multiple-kernel extension of this method leads to the use of only one of the input matrices, which does not fit the goal of gaining information from all data sources. Therefore, we present a scoring function to determine the impact of each input matrix. The approach enables visualizing the integrated data and subsequent clustering for cancer subtype identification. Due to the nature of the method, no free parameters have to be set. We apply the methodology to five different cancer data sets and demonstrate its advantages in terms of results and usability.